Pharmaceuticals

Benchtop Bioreactors Market Size and Growth Forecast for Businesses 2025–2029

November 20, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Benchtop Bioreactors Market?

The benchtop bioreactors market has seen rapid expansion over recent years. It is anticipated to grow from $0.98 billion in 2024 to $1.08 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 10.5%. This historical growth can be attributed to a heightened focus on cell-based research, an increase in funding for academic and research institutions, a rising interest in tissue engineering, the expanding utilization of microbial fermentation processes, and a growing adoption in pilot-scale biomanufacturing.

The benchtop bioreactors market size is projected to witness substantial expansion in the upcoming years. This market is predicted to reach $1.59 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.1%. Several factors are expected to fuel this growth during the projected timeframe, including the increasing need for personalized medicine, the proliferation of biotechnology startups, escalating government funding for biotech infrastructure, greater integration of single-use bioreactor systems, and the expansion of contract research and manufacturing organizations. Prominent trends over the forecast period are expected to involve enhancements in sensor and monitoring technologies, sophisticated process control and automation functionalities, novel single-use bioreactor designs, the incorporation of artificial intelligence and machine learning within bioprocessing, and advancements in miniaturized bioprocess systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27220&type=smp

What Are The Main Drivers Boosting The Benchtop Bioreactors Industry’s Expansion?

The increasing utilization of gene therapies is projected to fuel the expansion of the benchtop bioreactors market in the forthcoming period. Gene therapy is a medical approach that entails altering or substituting faulty genes to address or prevent diseases. The escalating demand for gene therapy results from advancements in genetic sequencing and diagnostics, which facilitate the precise identification of disease-causing genes for targeted intervention. Benchtop bioreactors accelerate gene therapies by providing exact control and efficient production of gene-modified cells. They support swift research and small-scale manufacturing, thus enhancing process speed and consistency. For example, in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, indicated that the Food and Drug Administration (FDA) approved six gene therapy products in 2023, marking an increase from five approvals in 2022. As a result, the growing acceptance of gene therapies is propelling the growth of the benchtop bioreactors market.

What Are The Key Segments In The Benchtop Bioreactors Market?

The benchtop bioreactors market covered in this report is segmented

1) By Type: Swing-Style Bioreactors, Stirred-Tank Bioreactors, Wave-Mixed Bioreactors, Airlift Bioreactors, Bubble Column Bioreactors

2) By Control Type: Automated Bioreactors, Manual Bioreactors, Continuous Bioreactors, Batch Bioreactors

3) By Material: Stainless Steel, Glass, Plastic, Composite Materials

4) By Application: Research And Development, Process Development, Bioproduction, Quality Control, Training And Education

5) By End User: Pharmaceutical Companies, Biotechnology Companies, Academic And Research Institutes, Contract Research Organizations (CROs), Food And Beverage Industry

Subsegments:

1) By Swing-Style Bioreactors: Single-Use Swing Bioreactors, Multi-Use Swing Bioreactors, Compact Swing Bioreactors, Automated Swing Bioreactors

2) By Stirred-Tank Bioreactors: Single-Use Stirred-Tank Bioreactors, Glass Stirred-Tank Bioreactors, Stainless-Steel Stirred-Tank Bioreactors, Modular Stirred-Tank Bioreactors, Automated Stirred-Tank Bioreactors

3) By Wave-Mixed Bioreactors: Single-Use Wave-Mixed Bioreactors, Dual-Motion Wave-Mixed Bioreactors, Automated Wave-Mixed Bioreactors, Compact Wave-Mixed Bioreactors

4) By Airlift Bioreactors: Internal Loop Airlift Bioreactors, External Loop Airlift Bioreactors, Single-Use Airlift Bioreactors, Pilot-Scale Airlift Bioreactors

5) By Bubble Column Bioreactors: Vertical Bubble Column Bioreactors, Single-Use Bubble Column Bioreactors, Gas-Lift Bubble Column Bioreactors, Automated Bubble Column Bioreactors

What Long-Term Trends Will Shape The Future Growth Of The Benchtop Bioreactors Industry?

Leading companies within the benchtop bioreactors market are actively pursuing the creation of advanced solutions, specifically benchtop fermenters, aiming to improve both precise control and scalability for research activities and modest production needs. These compact, laboratory-sized bioreactors, known as benchtop fermenters, are engineered for the regulated growth of microorganisms or cells, serving to facilitate research and low-volume production. An example of this innovation is seen in September 2024, when VFL Sciences Private Limited, an Indian biotechnology equipment producer, introduced its GreatFlo series of benchtop fermenters or bioreactors. This adaptable and modular product line is designed for straightforward scale-up processes and ensures reliable reproducibility across various fermentation and cell culture uses. The fermenters enable smooth parallel operation, offering flexible expansion capabilities ranging from 2 to 16 vessels, with each vessel providing a working volume of 200-500 ml. Equipped with Peltier-controlled heating and cooling mechanisms, along with exhaust condensers and software adhering to 21 CFR Part 11, the system offers exact control over agitation, pH levels, dissolved oxygen, and the mixing of individual gases.

Which Leading Players Are Enhancing Their Benchtop Bioreactors Market Presence Worldwide?

Major companies operating in the benchtop bioreactors market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, GE Healthcare, Sartorius AG, Eppendorf AG, Solaris Biotech Solutions, IKA-Werke GmbH And Co. KG, GPC Bio USA, Praj HiPurity Systems Limited., PBS Biotech Inc., Bioengineering AG, Broadley‑James Ltd., Infors HT, Solida Biotech, Bbi-biotech GmbH, Applikon Biotechnology B.V., Labfirst Scientific Instruments Co. Ltd, Pharsol Ltd., Uma Pharmatech Machinery.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/benchtop-bioreactors-global-market-report

What Are The Regional Market Dynamics Impacting The Benchtop Bioreactors Industry?

North America was the largest region in the benchtop bioreactors market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the benchtop bioreactors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Benchtop Bioreactors Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27220&type=smp

Browse Through More Reports Similar to the Global Benchtop Bioreactors Market 2025, By The Business Research Company

Hydraulic Fracturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hydraulic-fracturing-global-market-report

Hydraulic Excavator Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hydraulic-excavator-global-market-report

Hydraulic Equipment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hydraulic-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795